Welcome to our dedicated page for GLOBE LIFE SEC filings (Ticker: GL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Globe Life Inc. filings document operating results, governance and capital-structure disclosures for an insurance holding company focused on life and supplemental health insurance. Current reports include earnings releases furnished on Form 8-K, with disclosures on net income, net operating income, underwriting margins, premium revenue and guidance.
Proxy and governance filings cover director elections, shareholder voting results, advisory executive compensation matters, board composition, non-employee director compensation and executive retirement plan amendments. The filing record also identifies registered securities including common stock and subordinated debt, alongside recurring disclosures tied to shareholder meetings and corporate governance procedures.
Globe Life Inc. shareholder Frank Svoboda filed a notice to sell 16,500 shares of common stock, to be delivered through a stock option exercise with proceeds directed to Globe Life Inc. The filing lists Apex Clearing as the broker and notes trading on the NYSE.
Over the prior three months, Svoboda reported sales of 20,000 shares on May 22, 2026, 10,000 shares on June 11, 2026, and 10,000 shares on June 12, 2026, each in Globe Life common stock.
Globe Life Inc. executive Robert Brian Mitchell, EVP, General Counsel and CRO, exercised 23,000 stock options at an exercise price of $103.23 per share on August 7, 2026, receiving 23,000 shares of common stock. He then sold 23,000 shares in multiple open-market transactions at prices ranging from $182.38 to $185.50 per share. Following these transactions, he continues to hold common stock indirectly through the Mitchell Family Trust, a Son's Trust, and a 401(k) Plan, including shares accumulated via a brokerage dividend reinvestment plan.
Globe Life Inc. reported that board member David A. Rodriguez retired from its Board of Directors effective August 4, 2026, for personal reasons. The company stated that his departure was not the result of any disagreement concerning its operations, policies, or practices.
Globe Life’s common stock, with a par value of $1.00 per share, trades on the New York Stock Exchange under the symbol GL, and its 4.250% Junior Subordinated Debentures trade on the New York Stock Exchange under the symbol GL PRD.
GLOBE LIFE INC. reports that Co-Chairman & CEO James Matthew Darden exercised employee stock options for 50,000 shares of common stock at $98.32 per share on July 31, 2026, then sold 49,600 shares at an average $182.4253 and 400 shares at $183.3575. He also reports 4,202.03 shares held indirectly through a 401(k) plan.
Globe Life Inc. reports its quarterly institutional investment holdings as an investment manager. The report covers a Form 13F Information Table Entry Total of 2 positions, with a combined Form 13F Information Table Value Total of $421,612,883. No other included managers are listed, indicating Globe Life is the sole reporting manager for these positions.
Globe Life Inc. EVP & CFO Thomas Peter Kalmbach exercised employee stock options for 21,000 shares of common stock on July 30, 2026, at exercise prices of $103.23 and $120.49 per share, then sold 21,000 shares in transactions described as open market or private sales at prices ranging from $178.64 to $181.98 per share. After these trades, 1,158.515 shares were reported as held indirectly through a 401(k) Plan.
GLOBE LIFE INC. executive Michael Clay Majors, EVP and Chief Strategy Officer, exercised employee stock options for 37,000 shares of common stock on 2026-07-29 at an exercise price of $103.23 per share and immediately received 37,000 shares. On the same date, he sold 33,500 shares at a reported price of $178.5613 per share, with footnotes stating actual sale prices ranged from $178.115 to $179.04 per share, and sold an additional 3,500 shares at a reported price of $179.3490 per share within a range of $179.05 to $179.665 per share.
Globe Life EVP & CFO Thomas Peter Kalmbach reported option-related transactions dated 2026-07-28. He exercised employee stock options covering 25,650 shares of common stock at strike prices of $120.49 and $128.40, acquired the underlying shares, and then sold 25,650 shares in multiple open-market or private transactions at prices ranging from $177.31 to $179.52 per share. He also reports indirect ownership of 1,158.515 shares through a 401(k) plan. The Rule 10b5-1 trading-plan checkbox is unchecked.